{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:55:29Z","timestamp":1753890929254,"version":"3.41.2"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T00:00:00Z","timestamp":1596758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.01674","type":"journal-article","created":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T11:27:33Z","timestamp":1596799653000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["New MoDC-Targeting TNF Fusion Proteins Enhance Cyclic Di-GMP Vaccine Adjuvanticity in Middle-Aged and Aged Mice"],"prefix":"10.3389","volume":"11","author":[{"given":"Himanshu","family":"Gogoi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samira","family":"Mansouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divya S.","family":"Katikaneni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,8,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"9696","DOI":"10.1101\/2020.03.15.20036293","article-title":"Demographic science aids in understanding the spread and fatality rates of COVID-19","volume":"117","author":"Dowd","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"B2","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41591-019-0381-y","article-title":"A clinically meaningful metric of immune age derived from high-dimensional longitudinal monitoring","volume":"25","author":"Alpert","year":"2019","journal-title":"Nat Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"5350","DOI":"10.1016\/j.vaccine.2017.07.062","article-title":"Personalized vaccinology: a review","volume":"36","author":"Poland","year":"2018","journal-title":"Vaccine."},{"key":"B4","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S1473-3099(11)70295-X","article-title":"Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis","volume":"12","author":"Osterholm","year":"2012","journal-title":"Lancet Infect Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1093\/ije\/31.4.776","article-title":"Population ageing in the United States of America: implications for public programmes","volume":"31","author":"Wiener","year":"2002","journal-title":"Int J Epidemiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.1172\/JCI57834","article-title":"Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies","volume":"121","author":"Sasaki","year":"2011","journal-title":"J Clin Invest."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e34145","DOI":"10.1371\/journal.pone.0034145","article-title":"Age affects quantity but not quality of antibody responses after vaccination with an inactivated flavivirus vaccine against tick-borne encephalitis","volume":"7","author":"Stiasny","year":"2012","journal-title":"PLoS ONE."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1093\/cid\/civ686","article-title":"The impact of age on the efficacy of 13-valent pneumococcal conjugate vaccine in elderly","volume":"61","author":"van Werkhoven","year":"2015","journal-title":"Clin Infect Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1056\/NEJMoa1408544","article-title":"Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults","volume":"372","author":"Bonten","year":"2015","journal-title":"N Engl J Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.coi.2013.07.008","article-title":"Perspectives on vaccine development for the elderly","volume":"25","author":"Oviedo-Orta","year":"2013","journal-title":"Curr Opin Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.coi.2013.05.014","article-title":"Vaccine strategies to enhance immune responses in the aged","volume":"25","author":"Lefebvre","year":"2013","journal-title":"Curr Opin Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.imlet.2014.06.006","article-title":"Immunosenescence and vaccine failure in the elderly: strategies for improving response","volume":"162","author":"Boraschi","year":"2014","journal-title":"Immunol Lett."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.celrep.2015.04.031","article-title":"Direct activation of sting in the tumor microenvironment leads to potent and systemic tumor regression and immunity","volume":"11","author":"Corrales","year":"2015","journal-title":"Cell Rep."},{"key":"B14","doi-asserted-by":"publisher","first-page":"283ra52","DOI":"10.1126\/scitranslmed.aaa4306","article-title":"STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade","volume":"7","author":"Fu","year":"2015","journal-title":"Sci Transl Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1177\/2051013613501988","article-title":"Rationale, progress and development of vaccines utilizing STING-activating cyclic dinucleotide adjuvants","volume":"1","author":"Dubensky","year":"2013","journal-title":"Ther Adv Vaccines."},{"key":"B16","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1016\/j.vaccine.2010.02.081","article-title":"The potential of 3\u2032, 5\u2032-cyclic diguanylic acid (c-di-GMP) as an effective vaccine adjuvant","volume":"28","author":"Chen","year":"2010","journal-title":"Vaccine."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.3389\/fimmu.2017.01223","article-title":"Mucosal administration of cycle-di-nucleotide-adjuvanted virosomes efficiently induces protection against influenza H5N1 in Mice","volume":"8","author":"Ebensen","year":"2017","journal-title":"Front Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1007\/s00262-015-1713-5","article-title":"STING activator c-di-GMP enhances the anti-tumor effects of peptide vaccines in melanoma-bearing mice","volume":"64","author":"Wang","year":"2015","journal-title":"Cancer Immunol Immunother."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1172\/JCI79915","article-title":"Nanoparticulate STING agonists are potent lymph node-targeted vaccine adjuvants","volume":"125","author":"Hanson","year":"2015","journal-title":"J Clin Invest."},{"key":"B20","doi-asserted-by":"publisher","first-page":"492","DOI":"10.4049\/jimmunol.1301812","article-title":"MPYS\/STING-mediated TNF-\u03b1, not type I IFN, is essential for the mucosal adjuvant activity of (3\u2032-5\u2032)-cyclic-di-guanosine-monophosphate in vivo","volume":"192","author":"Blaauboer","year":"2014","journal-title":"J Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e06670","DOI":"10.7554\/eLife.06670","article-title":"The mucosal adjuvant cyclic di-GMP enhances antigen uptake and selectively activates pinocytosis-efficient cells in vivo","volume":"4","author":"Blaauboer","year":"2015","journal-title":"Elife."},{"key":"B22","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41385-018-0098-0","article-title":"Immature lung TNFR2(-) conventional DC 2 subpopulation activates moDCs to promote cyclic di-GMP mucosal adjuvant responses in vivo","volume":"12","author":"Mansouri","year":"2019","journal-title":"Mucosal Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area","volume":"323","author":"Richardson","year":"2020","journal-title":"JAMA"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1086\/587897","article-title":"Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States","volume":"46","author":"Tsai","year":"2008","journal-title":"Clin Infect Dis."},{"key":"B25","doi-asserted-by":"crossref","first-page":"26350","DOI":"10.1016\/S0021-9258(19)74322-1","article-title":"Human tumor necrosis factor alpha (TNF alpha) mutants with exclusive specificity for the 55-kDa or 75-kDa TNF receptors","volume":"268","author":"Loetscher","year":"1993","journal-title":"J Biol Chem."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.4049\/jimmunol.1102744","article-title":"CD64 expression distinguishes monocyte-derived and conventional dendritic cells and reveals their distinct role during intramuscular immunization","volume":"188","author":"Langlet","year":"2012","journal-title":"J Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nri3582","article-title":"The function of Fc\u03b3 receptors in dendritic cells and macrophages","volume":"14","author":"Guilliams","year":"2014","journal-title":"Nat Rev Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"135244","DOI":"10.1101\/2020.06.04.135244","article-title":"Mucosal vaccine adjuvant cyclic di-GMP differentiates lung moDCs into Bcl6+ and Bcl6- mature moDCs to induce lung memory CD4+ TH cells and lung TFH cells respectively","volume":"2020","author":"Mansouri","year":"2020","journal-title":"bioRxiv."},{"key":"B29","doi-asserted-by":"publisher","first-page":"5869","DOI":"10.1016\/j.biomaterials.2009.07.009","article-title":"The use of a mutant TNF-\u03b1 as a vaccine adjuvant for the induction of mucosal immune responses","volume":"30","author":"Kayamuro","year":"2009","journal-title":"Biomaterials."},{"key":"B30","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.smim.2018.10.010","article-title":"Vaccination in the elderly: the challenge of immune changes with aging","volume":"40","author":"Ciabattini","year":"2018","journal-title":"Semin Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41435-018-0029-9","article-title":"TMEM173 variants and potential importance to human biology and disease","volume":"20","author":"Patel","year":"2019","journal-title":"Genes Immun."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.1016\/j.vaccine.2019.04.004","article-title":"STING pathway stimulation results in a differentially activated innate immune phenotype associated with low nitric oxide and enhanced antibody titers in young and aged mice","volume":"37","author":"Darling","year":"2019","journal-title":"Vaccine."},{"key":"B33","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.3389\/fimmu.2019.03006","article-title":"Combination of STING pathway agonist with saponin is an effective adjuvant in immunosenescent Mice","volume":"10","author":"Vassilieva","year":"2019","journal-title":"Front Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/S0140-6736(05)67339-4","article-title":"Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review","volume":"366","author":"Jefferson","year":"2005","journal-title":"Lancet."},{"key":"B35","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nri2508","article-title":"B-cell responses to vaccination at the extremes of age","volume":"9","author":"Siegrist","year":"2009","journal-title":"Nat Rev Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41479-017-0045-y","article-title":"Pneumococcal vaccination in older persons: where are we today?","volume":"10","author":"van Buynder","year":"2018","journal-title":"Pneumonia (Nathan)."},{"key":"B37","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/cei.12881","article-title":"Innate immune responses in the ageing lung","volume":"187","author":"Boe","year":"2017","journal-title":"Clin Exp Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"4973","DOI":"10.1016\/j.vaccine.2011.04.094","article-title":"Intranasal c-di-GMP-adjuvanted plant-derived H5 influenza vaccine induces multifunctional Th1 CD4+ cells and strong mucosal and systemic antibody responses in mice","volume":"29","author":"Madhun","year":"2011","journal-title":"Vaccine."},{"key":"B39","doi-asserted-by":"publisher","first-page":"eaau0810","DOI":"10.1126\/science.aau0810","article-title":"Pulmonary surfactant-biomimetic nanoparticles potentiate heterosubtypic influenza immunity","volume":"367","author":"Wang","year":"2020","journal-title":"Science."},{"key":"B40","doi-asserted-by":"publisher","first-page":"4676","DOI":"10.1016\/j.vaccine.2008.06.099","article-title":"c-di-GMP is an effective immunomodulator and vaccine adjuvant against pneumococcal infection","volume":"26","author":"Ogunniyi","year":"2008","journal-title":"Vaccine."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/j.celrep.2018.04.003","article-title":"STING-activating adjuvants elicit a Th17 immune response and protect against mycobacterium tuberculosis infection","volume":"23","author":"Van Dis","year":"2018","journal-title":"Cell Rep."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1016\/j.vaccine.2017.02.064","article-title":"Sublingual targeting of STING with 3\u20323\u2032-cGAMP promotes systemic and mucosal immunity against anthrax toxins","volume":"35","author":"Martin","year":"2017","journal-title":"Vaccine."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1016\/j.vaccine.2009.12.045","article-title":"The member of the cyclic di-nucleotide family bis-(3\u2032, 5\u2032)-cyclic dimeric inosine monophosphate exerts potent activity as mucosal adjuvant","volume":"28","author":"Libanova","year":"2009","journal-title":"Vaccine."},{"key":"B44","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.bbrc.2009.07.061","article-title":"3\u2032,5\u2032-Cyclic diguanylic acid elicits mucosal immunity against bacterial infection","volume":"387","author":"Yan","year":"2009","journal-title":"Biochem Biophys Res Commun."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1016\/j.intimp.2011.03.024","article-title":"c-di-GMP protects against intranasal Acinetobacter baumannii infection in mice by chemokine induction and enhanced neutrophil recruitment","volume":"11","author":"Zhao","year":"2010","journal-title":"Int Immunopharmacol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"4867","DOI":"10.1016\/j.vaccine.2009.04.053","article-title":"c-di-GMP as a vaccine adjuvant enhances protection against systemic methicillin-resistant Staphylococcus aureus (MRSA) infection","volume":"27","author":"Hu","year":"2009","journal-title":"Vaccine."},{"key":"B47","doi-asserted-by":"publisher","first-page":"4942","DOI":"10.1128\/IAI.01762-06","article-title":"Cyclic di-GMP stimulates protective innate immunity in bacterial pneumonia","volume":"75","author":"Karaolis","year":"2007","journal-title":"Infect Immun."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01674\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,28]],"date-time":"2021-03-28T00:09:56Z","timestamp":1616890196000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01674\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,7]]},"references-count":47,"alternative-id":["10.3389\/fimmu.2020.01674"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.01674","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2020,8,7]]},"article-number":"1674"}}